VINSSEN Receives Type Approval for Maritime Fuel Cell Stack from RINA
SEOUL, South Korea, March 21, 2025 /PRNewswire/ -- VINSSEN, a maritime decarbonization…
Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is…
ENNOVI Enhances Cell Contacting System Performance with Innovative Adhesive-Free Lamination Technology
The patent-pending process combines manufacturing efficiency, design flexibility and enhanced performance compared…
Press Release: Sanofi to acquire Dren Bios bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell…
Leading Academic and Manufacturing Organizations Join Ori Biotechs Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies
Preferred Partner Network (PPN) members will become Centers of Excellence for the…
Thailand Approves Sunwoda to Invest More Than US$1 billion in EV Battery Cell Plants
BANGKOK, March 13, 2025 /PRNewswire/ -- Thailand's Commission on the National Competitiveness…
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies
Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx’s Novel PluriFreeze™ Cryopreservation…
NewBiologix Announces White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene Therapies
March 05, 2025 03:00 ET | Source: NewBiologix LAUSANNE, Switzerland, March 05,…
![Zelluna ASA [ZLNA]: The first ever cell therapy company to list on the Oslo Stock Exchange following successful completion of the business combination and private placement](https://i1.wp.com/ml-eu.globenewswire.com/media/MjU1NjVjOWEtMTBjOC00MTE0LWI0NTUtYjdlMjkzODM0MzYzLTEyMjA5NDY=/tiny/Zelluna-ASA.png?w=420&resize=420,280&ssl=1 "Zelluna ASA [ZLNA]: The first ever cell therapy company to list on the Oslo Stock Exchange following successful completion of the business combination and private placement")
Zelluna ASA [ZLNA]: The first ever cell therapy company to list on the Oslo Stock Exchange following successful completion of the business combination and private placement
March 03, 2025 10:46 ET | Source: Zelluna ASA Oslo, Norway, 03…
IN8bio Announces Advanced Gamma-Delta () T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
March 03, 2025 09:28 ET | Source: IN8bio, Inc Proprietary platform represents…